[go: up one dir, main page]

IL118932A0 - Controlled release tablets - Google Patents

Controlled release tablets

Info

Publication number
IL118932A0
IL118932A0 IL11893296A IL11893296A IL118932A0 IL 118932 A0 IL118932 A0 IL 118932A0 IL 11893296 A IL11893296 A IL 11893296A IL 11893296 A IL11893296 A IL 11893296A IL 118932 A0 IL118932 A0 IL 118932A0
Authority
IL
Israel
Prior art keywords
controlled release
release tablets
tablets
controlled
release
Prior art date
Application number
IL11893296A
Original Assignee
Dexcel Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dexcel Ltd filed Critical Dexcel Ltd
Priority to IL11893296A priority Critical patent/IL118932A0/en
Publication of IL118932A0 publication Critical patent/IL118932A0/en
Priority to AU33522/97A priority patent/AU3352297A/en
Priority to PCT/GB1997/001770 priority patent/WO1998003161A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
IL11893296A 1996-07-24 1996-07-24 Controlled release tablets IL118932A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IL11893296A IL118932A0 (en) 1996-07-24 1996-07-24 Controlled release tablets
AU33522/97A AU3352297A (en) 1996-07-24 1997-07-01 Controlled release tablets
PCT/GB1997/001770 WO1998003161A1 (en) 1996-07-24 1997-07-01 Controlled release tablets

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL11893296A IL118932A0 (en) 1996-07-24 1996-07-24 Controlled release tablets

Publications (1)

Publication Number Publication Date
IL118932A0 true IL118932A0 (en) 1996-10-31

Family

ID=11069113

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11893296A IL118932A0 (en) 1996-07-24 1996-07-24 Controlled release tablets

Country Status (3)

Country Link
AU (1) AU3352297A (en)
IL (1) IL118932A0 (en)
WO (1) WO1998003161A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6251432B1 (en) 1999-07-01 2001-06-26 Abbott Laboratories Sustained release dosage form unit having latex coating and method of making the same
AR036797A1 (en) 2001-10-15 2004-10-06 Ferring Bv A METHOD TO PREPARE A PHARMACEUTICAL COMPOSITION THAT INCLUDES 5-AMINOSALICILIC ACID TO USE IN THE TREATMENT OF ULCEROSE COLITIS AND CROHN DISEASES
CA2501324A1 (en) * 2002-10-30 2004-05-21 Pharmacia Corporation Oral extended release tablets and methods of making and using the same
JP2007523664A (en) 2003-04-23 2007-08-23 フェリング ベスローテン フェンノートシャップ Sachet for pharmaceutical composition
EP1547601A1 (en) 2003-12-23 2005-06-29 Ferring B.V. Coating method

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4445641A (en) * 1982-01-08 1984-05-01 Bend Research, Inc. Controlled-release dispenser
AU608891B2 (en) * 1987-09-24 1991-04-18 Merck & Co., Inc. Solubility modulated drug delivery device
IE60383B1 (en) * 1988-05-27 1994-07-13 Elan Corp Plc Controlled release pharmaceutical formulation
DE4230563A1 (en) * 1992-09-12 1994-03-17 Boehringer Ingelheim Kg High-dose compact granules and tablets made therefrom
US5458887A (en) * 1994-03-02 1995-10-17 Andrx Pharmaceuticals, Inc. Controlled release tablet formulation

Also Published As

Publication number Publication date
AU3352297A (en) 1998-02-10
WO1998003161A1 (en) 1998-01-29

Similar Documents

Publication Publication Date Title
AU3406497A (en) Controlled release tablet
CY2284B1 (en) Tablet with controlled release of alfuzosine chlorydrate
EG24198A (en) Extended release formulation
PL346545A1 (en) Immediate release tablet
SG71879A1 (en) Controlled release compositions
EG23934A (en) Poroxetine controlled release compositions
AU132520S (en) Tablet
SG71789A1 (en) Controlled release compositions
GB9413957D0 (en) Release devices
AU5171196A (en) Controlled release tablet
ZA955592B (en) Controlled release fertilizers
AU133610S (en) Tablet
ZA959221B (en) Cisapride extended release
GB9703426D0 (en) Release mechanism
GB9826000D0 (en) Tablets
IL118932A0 (en) Controlled release tablets
GB9915929D0 (en) Novel release latch-c-i-p
GB9507139D0 (en) Release units
EP0906754A4 (en) Rapid-release s1452 tablets
IL117677A0 (en) Controlled release tablets
AU2911997A (en) Controlled release fertilisers
GB9711946D0 (en) Release devices
HUP9902293A3 (en) Stabilized antihepatitis-b vaccine tablets
GB9506864D0 (en) Release device
HK1019551A (en) Controlled release tablet